Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market, Global Outlook and Forecast 2023-2029

Report ID: MMG174493 | Category: Pharma & Healthcare | Pages: 112 | Format: PDF | Published Date: August 16,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3250.00 Multi User-$4225.00

Report Description
View Table of Contents

Report Summary

This report aims to provide a comprehensive presentation of the global market for Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS). This report contains market size and forecasts of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) in global, including the following market information:
Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) companies in 2022 (%)
The global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Live Vaccine Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) include CNADC, Boehringer-Ingelheim, MSD Animal Health, Sinopharm, Ceva, Chengdu Tianbang Biological Products Co., Ltd., Tianjin Ruipu Biological Technology Co., Ltd., Qilu Animal Health and Guangdong Wens Dahuanong Biotechnology Co., Ltd., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Segment Percentages, by Type, 2022 (%)
    Live Vaccine
    Inactivated Vaccine
Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Segment Percentages, by Application, 2022 (%)
    Government Tender
    Marketing
Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) revenues share in global market, 2022 (%)
Key companies Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    CNADC
    Boehringer-Ingelheim
    MSD Animal Health
    Sinopharm
    Ceva
    Chengdu Tianbang Biological Products Co., Ltd.
    Tianjin Ruipu Biological Technology Co., Ltd.
    Qilu Animal Health
    Guangdong Wens Dahuanong Biotechnology Co., Ltd.
    CAVAC
    Komipharm
    Agrovet
    Bioveta
    Jinyu Bio-Technology
    Phibro Animal Health
    Tiankang
    Zoetis
    Guangdong Yongshun Biological Pharmaceutical Co Ltd
    Plec Bioengineering Co., Ltd.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS), market overview.
Chapter 2: Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) market size in revenue and volume.
Chapter 3: Detailed analysis of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
    1.1 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Overall Market Size
    2.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size: 2022 VS 2029
    2.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue, Prospects & Forecasts: 2018-2029
    2.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales: 2018-2029
3 Company Landscape
    3.1 Top Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Players in Global Market
    3.2 Top Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Companies Ranked by Revenue
    3.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Companies
    3.4 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Companies
    3.5 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price by Manufacturer (2018-2023)
    3.6 Top 3 and Top 5 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Companies in Global Market, by Revenue in 2022
    3.7 Global Manufacturers Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Type
    3.8 Tier 1, Tier 2 and Tier 3 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Players in Global Market
        3.8.1 List of Global Tier 1 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Companies
        3.8.2 List of Global Tier 2 and Tier 3 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Companies
4 Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size Markets, 2022 & 2029
        4.1.2 Live Vaccine
        4.1.3 Inactivated Vaccine
    4.2 By Type - Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue & Forecasts
        4.2.1 By Type - Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue, 2018-2023
        4.2.2 By Type - Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue, 2024-2029
        4.2.3 By Type - Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share, 2018-2029
    4.3 By Type - Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales & Forecasts
        4.3.1 By Type - Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, 2018-2023
        4.3.2 By Type - Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, 2024-2029
        4.3.3 By Type - Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share, 2018-2029
    4.4 By Type - Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size, 2022 & 2029
        5.1.2 Government Tender
        5.1.3 Marketing
    5.2 By Application - Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue & Forecasts
        5.2.1 By Application - Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue, 2018-2023
        5.2.2 By Application - Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue, 2024-2029
        5.2.3 By Application - Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share, 2018-2029
    5.3 By Application - Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales & Forecasts
        5.3.1 By Application - Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, 2018-2023
        5.3.2 By Application - Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, 2024-2029
        5.3.3 By Application - Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share, 2018-2029
    5.4 By Application - Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
    6.1 By Region - Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size, 2022 & 2029
    6.2 By Region - Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue & Forecasts
        6.2.1 By Region - Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue, 2018-2023
        6.2.2 By Region - Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue, 2024-2029
        6.2.3 By Region - Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share, 2018-2029
    6.3 By Region - Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales & Forecasts
        6.3.1 By Region - Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, 2018-2023
        6.3.2 By Region - Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, 2024-2029
        6.3.3 By Region - Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share, 2018-2029
    6.4 North America
        6.4.1 By Country - North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue, 2018-2029
        6.4.2 By Country - North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, 2018-2029
        6.4.3 US Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size, 2018-2029
        6.4.4 Canada Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size, 2018-2029
        6.4.5 Mexico Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size, 2018-2029
    6.5 Europe
        6.5.1 By Country - Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue, 2018-2029
        6.5.2 By Country - Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, 2018-2029
        6.5.3 Germany Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size, 2018-2029
        6.5.4 France Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size, 2018-2029
        6.5.5 U.K. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size, 2018-2029
        6.5.6 Italy Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size, 2018-2029
        6.5.7 Russia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size, 2018-2029
        6.5.8 Nordic Countries Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size, 2018-2029
        6.5.9 Benelux Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size, 2018-2029
    6.6 Asia
        6.6.1 By Region - Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue, 2018-2029
        6.6.2 By Region - Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, 2018-2029
        6.6.3 China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size, 2018-2029
        6.6.4 Japan Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size, 2018-2029
        6.6.5 South Korea Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size, 2018-2029
        6.6.6 Southeast Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size, 2018-2029
        6.6.7 India Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size, 2018-2029
    6.7 South America
        6.7.1 By Country - South America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue, 2018-2029
        6.7.2 By Country - South America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, 2018-2029
        6.7.3 Brazil Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size, 2018-2029
        6.7.4 Argentina Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size, 2018-2029
    6.8 Middle East & Africa
        6.8.1 By Country - Middle East & Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue, 2018-2029
        6.8.2 By Country - Middle East & Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, 2018-2029
        6.8.3 Turkey Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size, 2018-2029
        6.8.4 Israel Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size, 2018-2029
        6.8.5 Saudi Arabia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size, 2018-2029
        6.8.6 UAE Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size, 2018-2029
7 Manufacturers & Brands Profiles
    7.1 CNADC
        7.1.1 CNADC Company Summary
        7.1.2 CNADC Business Overview
        7.1.3 CNADC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Major Product Offerings
        7.1.4 CNADC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Revenue in Global (2018-2023)
        7.1.5 CNADC Key News & Latest Developments
    7.2 Boehringer-Ingelheim
        7.2.1 Boehringer-Ingelheim Company Summary
        7.2.2 Boehringer-Ingelheim Business Overview
        7.2.3 Boehringer-Ingelheim Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Major Product Offerings
        7.2.4 Boehringer-Ingelheim Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Revenue in Global (2018-2023)
        7.2.5 Boehringer-Ingelheim Key News & Latest Developments
    7.3 MSD Animal Health
        7.3.1 MSD Animal Health Company Summary
        7.3.2 MSD Animal Health Business Overview
        7.3.3 MSD Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Major Product Offerings
        7.3.4 MSD Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Revenue in Global (2018-2023)
        7.3.5 MSD Animal Health Key News & Latest Developments
    7.4 Sinopharm
        7.4.1 Sinopharm Company Summary
        7.4.2 Sinopharm Business Overview
        7.4.3 Sinopharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Major Product Offerings
        7.4.4 Sinopharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Revenue in Global (2018-2023)
        7.4.5 Sinopharm Key News & Latest Developments
    7.5 Ceva
        7.5.1 Ceva Company Summary
        7.5.2 Ceva Business Overview
        7.5.3 Ceva Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Major Product Offerings
        7.5.4 Ceva Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Revenue in Global (2018-2023)
        7.5.5 Ceva Key News & Latest Developments
    7.6 Chengdu Tianbang Biological Products Co., Ltd.
        7.6.1 Chengdu Tianbang Biological Products Co., Ltd. Company Summary
        7.6.2 Chengdu Tianbang Biological Products Co., Ltd. Business Overview
        7.6.3 Chengdu Tianbang Biological Products Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Major Product Offerings
        7.6.4 Chengdu Tianbang Biological Products Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Revenue in Global (2018-2023)
        7.6.5 Chengdu Tianbang Biological Products Co., Ltd. Key News & Latest Developments
    7.7 Tianjin Ruipu Biological Technology Co., Ltd.
        7.7.1 Tianjin Ruipu Biological Technology Co., Ltd. Company Summary
        7.7.2 Tianjin Ruipu Biological Technology Co., Ltd. Business Overview
        7.7.3 Tianjin Ruipu Biological Technology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Major Product Offerings
        7.7.4 Tianjin Ruipu Biological Technology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Revenue in Global (2018-2023)
        7.7.5 Tianjin Ruipu Biological Technology Co., Ltd. Key News & Latest Developments
    7.8 Qilu Animal Health
        7.8.1 Qilu Animal Health Company Summary
        7.8.2 Qilu Animal Health Business Overview
        7.8.3 Qilu Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Major Product Offerings
        7.8.4 Qilu Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Revenue in Global (2018-2023)
        7.8.5 Qilu Animal Health Key News & Latest Developments
    7.9 Guangdong Wens Dahuanong Biotechnology Co., Ltd.
        7.9.1 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Company Summary
        7.9.2 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Business Overview
        7.9.3 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Major Product Offerings
        7.9.4 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Revenue in Global (2018-2023)
        7.9.5 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Key News & Latest Developments
    7.10 CAVAC
        7.10.1 CAVAC Company Summary
        7.10.2 CAVAC Business Overview
        7.10.3 CAVAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Major Product Offerings
        7.10.4 CAVAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Revenue in Global (2018-2023)
        7.10.5 CAVAC Key News & Latest Developments
    7.11 Komipharm
        7.11.1 Komipharm Company Summary
        7.11.2 Komipharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Business Overview
        7.11.3 Komipharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Major Product Offerings
        7.11.4 Komipharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Revenue in Global (2018-2023)
        7.11.5 Komipharm Key News & Latest Developments
    7.12 Agrovet
        7.12.1 Agrovet Company Summary
        7.12.2 Agrovet Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Business Overview
        7.12.3 Agrovet Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Major Product Offerings
        7.12.4 Agrovet Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Revenue in Global (2018-2023)
        7.12.5 Agrovet Key News & Latest Developments
    7.13 Bioveta
        7.13.1 Bioveta Company Summary
        7.13.2 Bioveta Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Business Overview
        7.13.3 Bioveta Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Major Product Offerings
        7.13.4 Bioveta Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Revenue in Global (2018-2023)
        7.13.5 Bioveta Key News & Latest Developments
    7.14 Jinyu Bio-Technology
        7.14.1 Jinyu Bio-Technology Company Summary
        7.14.2 Jinyu Bio-Technology Business Overview
        7.14.3 Jinyu Bio-Technology Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Major Product Offerings
        7.14.4 Jinyu Bio-Technology Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Revenue in Global (2018-2023)
        7.14.5 Jinyu Bio-Technology Key News & Latest Developments
    7.15 Phibro Animal Health
        7.15.1 Phibro Animal Health Company Summary
        7.15.2 Phibro Animal Health Business Overview
        7.15.3 Phibro Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Major Product Offerings
        7.15.4 Phibro Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Revenue in Global (2018-2023)
        7.15.5 Phibro Animal Health Key News & Latest Developments
    7.16 Tiankang
        7.16.1 Tiankang Company Summary
        7.16.2 Tiankang Business Overview
        7.16.3 Tiankang Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Major Product Offerings
        7.16.4 Tiankang Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Revenue in Global (2018-2023)
        7.16.5 Tiankang Key News & Latest Developments
    7.17 Zoetis
        7.17.1 Zoetis Company Summary
        7.17.2 Zoetis Business Overview
        7.17.3 Zoetis Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Major Product Offerings
        7.17.4 Zoetis Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Revenue in Global (2018-2023)
        7.17.5 Zoetis Key News & Latest Developments
    7.18 Guangdong Yongshun Biological Pharmaceutical Co Ltd
        7.18.1 Guangdong Yongshun Biological Pharmaceutical Co Ltd Company Summary
        7.18.2 Guangdong Yongshun Biological Pharmaceutical Co Ltd Business Overview
        7.18.3 Guangdong Yongshun Biological Pharmaceutical Co Ltd Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Major Product Offerings
        7.18.4 Guangdong Yongshun Biological Pharmaceutical Co Ltd Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Revenue in Global (2018-2023)
        7.18.5 Guangdong Yongshun Biological Pharmaceutical Co Ltd Key News & Latest Developments
    7.19 Plec Bioengineering Co., Ltd.
        7.19.1 Plec Bioengineering Co., Ltd. Company Summary
        7.19.2 Plec Bioengineering Co., Ltd. Business Overview
        7.19.3 Plec Bioengineering Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Major Product Offerings
        7.19.4 Plec Bioengineering Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Revenue in Global (2018-2023)
        7.19.5 Plec Bioengineering Co., Ltd. Key News & Latest Developments
8 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Production Capacity, Analysis
    8.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Production Capacity, 2018-2029
    8.2 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Production Capacity of Key Manufacturers in Global Market
    8.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
    9.1 Market Opportunities & Trends
    9.2 Market Drivers
    9.3 Market Restraints
10 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Supply Chain Analysis
    10.1 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Industry Value Chain
    10.2 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Upstream Market
    10.3 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Downstream and Clients
    10.4 Marketing Channels Analysis
        10.4.1 Marketing Channels
        10.4.2 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
    12.1 Note
    12.2 Examples of Clients
    12.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market, Global Outlook and Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?